Pharmena S.A. (PHR) - Total Liabilities
Based on the latest financial reports, Pharmena S.A. (PHR) has total liabilities worth zł850.00K PLN (≈ $233.93K USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Pharmena S.A. - Total Liabilities Trend (2008–2024)
This chart illustrates how Pharmena S.A.'s total liabilities have evolved over time, based on quarterly financial data. See Pharmena S.A. working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Pharmena S.A. Competitors by Total Liabilities
The table below lists competitors of Pharmena S.A. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Cielo Waste Solutions Corp
V:CMC
|
Canada | CA$3.53 Million |
|
Sejin T.S Co.Ltd
KQ:067770
|
Korea | ₩1.08 Billion |
|
SARAMA RESOURCES LTD
F:48S1
|
Germany | €1.95 Million |
|
T.M.C. Industrial Public Company Limited
BK:TMC
|
Thailand | ฿82.89 Million |
|
Argentina Lithium & Energy Corp
V:LIT
|
Canada | CA$4.76 Million |
|
Agrogeneration
PA:ALAGR
|
France | €11.54 Million |
|
Bima Sakti Pertiwi Tbk PT
JK:PAMG
|
Indonesia | Rp163.87 Billion |
|
HYDROTOR SA
WAR:HDR
|
Poland | zł67.35 Million |
Liability Composition Analysis (2008–2024)
This chart breaks down Pharmena S.A.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see PHR market cap overview.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 13.52 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.08 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.07 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Pharmena S.A.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Pharmena S.A. (2008–2024)
The table below shows the annual total liabilities of Pharmena S.A. from 2008 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | zł1.11 Million ≈ $304.39K |
-41.97% |
| 2023-12-31 | zł1.91 Million ≈ $524.56K |
-90.16% |
| 2022-12-31 | zł19.37 Million ≈ $5.33 Million |
+19.04% |
| 2021-12-31 | zł16.27 Million ≈ $4.48 Million |
+44.03% |
| 2020-12-31 | zł11.30 Million ≈ $3.11 Million |
+67.53% |
| 2019-12-31 | zł6.74 Million ≈ $1.86 Million |
+38.57% |
| 2018-12-31 | zł4.87 Million ≈ $1.34 Million |
-35.47% |
| 2017-12-31 | zł7.54 Million ≈ $2.08 Million |
-9.57% |
| 2016-12-31 | zł8.34 Million ≈ $2.30 Million |
+28.60% |
| 2015-12-31 | zł6.49 Million ≈ $1.78 Million |
+71.61% |
| 2014-12-31 | zł3.78 Million ≈ $1.04 Million |
+50.80% |
| 2013-12-31 | zł2.51 Million ≈ $689.69K |
-3.98% |
| 2012-12-31 | zł2.61 Million ≈ $718.31K |
+63.31% |
| 2011-12-31 | zł1.60 Million ≈ $439.83K |
+75.05% |
| 2010-12-31 | zł912.97K ≈ $251.26K |
-2.34% |
| 2009-12-31 | zł934.89K ≈ $257.29K |
+27.15% |
| 2008-12-31 | zł735.26K ≈ $202.35K |
-- |
About Pharmena S.A.
Pharmena S.A., a biotechnology company, manufactures and sells active ingredients in various areas of medicines in Poland and internationally. The company offers dermatological cosmetics, including face, hair, and body care products, as well as dietary supplement. It offers its products under the Menavitin, Dermena, Allerco, and Thermi names. Pharmena S.A. was founded in 2002 and is based in Lódz… Read more